Pure Global AI
Disease / condition

Chronic Obstructive Pulmonary Disease clinical trials

Free access to 1,235 studies10+ countriesUpdated daily189 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
1,235
Total trials
10+
Countries
10+
Sponsors
189
Recruiting
By phase
N/A776
Phase 3114
Phase 4112
Phase 291
Phase 155
By status
Completed683
Recruiting189
Unknown140
Not yet recruit...131
Terminated44
Top countries
United States of America162
China147
United Kingdom97
France58
Germany53
Top sponsors
AstraZeneca75
Novartis Pharmaceu...40
Chiesi Farmaceutic...32
Pearl Therapeutics...17
Schön Klinik Berch...16
Recent trials
Latest clinical trials for Chronic Obstructive Pulmonary Disease
A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects
Chia Tai Tianqing Pharmaceutic... · China
NCT06408285Not yet recr...
Phase
Phase 1
Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers
Chiesi Farmaceutici S.p.A. · Bulgaria
NCT06395610Recruiting
Phase
Phase 1
Effect of CPAP on Respiratory Load in COPD
State Key Laboratory of Respir... · China
NCT06390631Recruiting
Efficacy & Safety of Dry Powder Ivy Extract (Syrup Prospan) Versus NAC Among COPD Patients
National University of Malaysi... · Malaysia
NCT06377410Not yet recr...
Accuracy of Accuhaler Tester, Ellipta Tester and Turbutester in Patients With Chronic Obstructive Pulmonary Disease
Thammasat University
NCT06346678Not yet recr...
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Maria Joyera Rodríguez · Germany,Netherlands,Spain,United Kingdom
NCT06334575Not yet recr...
Phase
Phase 4
A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot)
Chia Tai Tianqing Pharmaceutic... · China
NCT06326671Recruitment ...
Phase
Phase 1
Bufei Yishen Prescription on Patients With Frequent AECOPD in Stable Stage
Henan University of Traditiona...
NCT06326658Not yet recr...
Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.
Uppsala University · Sweden
NCT06335992Recruiting
Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique in COPD
Riphah International Universit... · Pakistan
NCT06308289Recruiting
Combined Effects of Ba-Duan-Jin Based Deep Breathing Exercises and Forced Expiratory Technique
Riphah International Universit... · Pakistan
NCT06332417Recruiting
Developing Personalised Relative Physical Activity Thresholds in COPD.
University of Leicester · United Kingdom
NCT06330623Recruiting
Decision Support on End-of-life Care Planning in Older Adults
National Taipei University of ...
NCT06314035Not yet recr...
A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) Hydrofluoroolefin (HFO) With a Spacer (Treatment B), BGF MDI Hydrofluoroalkane (HFA) With a Spacer (Treatment A), as Well as BGF MDI HFO Without a Spacer (Treatment C).
AstraZeneca · Germany,United Kingdom
NCT06297668Not yet recr...
Phase
Phase 1
Establishment of Human Lung Stem Cell Proliferation System and Organoid Construction in COPD
China-Japan Friendship Hospita...
NCT06275230Not yet recr...
Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging
Polarean, Inc. · United States of America
NCT06271408Recruiting
Phase
Phase 1
ANTES B+ Clinical Trial
Fundacio Privada Mon Clinic Ba... · Spain
NCT06282861Recruiting
Phase
Phase 4
Alveolar-capillary Reserve After Exercise in Chronic Obstructive Pulmonary Disease (COPD) (COP-DTPA)
Rigshospitalet, Denmark · Denmark
NCT06287476Not yet recr...
CHARM-COPD Program of Care
University Health Network, Tor... · Canada
NCT06253013Recruiting
Active Cycle of Breathing Techniques With and Without Acapella in COPD Patients
Riphah International Universit...
NCT06240936Not yet recr...
About this profile

Access comprehensive clinical trial information for Chronic Obstructive Pulmonary Disease through Pure Global AI's free database. This collection includes 1,235 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 189 trials are actively recruiting participants.

Research for Chronic Obstructive Pulmonary Disease is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include AstraZeneca and Novartis Pharmaceuticals. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 1,235 clinical trials studying Chronic Obstructive Pulmonary Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include AstraZeneca, Novartis Pharmaceuticals, Chiesi Farmaceutici S.p.A., among others.